In this respect, a plausible hypothesis is that C1orf64, in turn, may have a negative regulatory effect on AR function in breast cancer, which would provide a biological advantage for AR to repress C1orf64 expression in order to sustain its own transcriptional activity. Here, AR is linked to breast cancer.